Proteona announces multiple ASH presentations highlighting novel gene signatures in hematological cancers identified using advanced single-cell biomarker discovery platform
Meet Proteona at ASH 2021 SINGAPORE, Dec. 08, 2021 (GLOBE NEWSWIRE) — Proteona, a single-cell precision medicine company, today announced that three abstracts from the